# Trial of JYB1904 in Chronic Spontaneous Urticaria.

> **NCT06509334** · PHASE2 · RECRUITING · sponsor: **Jemincare** · enrollment: 135 (estimated)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **DRUG:** JYB1904
- **DRUG:** JYB1904
- **DRUG:** Omalizumab

## Key facts

- **NCT ID:** NCT06509334
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-04
- **Primary completion:** 2026-07-15
- **Final completion:** 2026-07-15
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06509334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06509334, "Trial of JYB1904 in Chronic Spontaneous Urticaria.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06509334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*